Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas
Open Access
- 1 January 1995
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control studyCancer, 1993
- Antitumor effects of analogs of LH-RH and somatostatin: Experimental and clinical studiesThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters events that accompany tumor regressionCancer, 1990
- Membrane Receptors for Peptides in Experimental and Human Pancreatic CancersPancreas, 1989
- Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995The American Journal of Surgery, 1988
- Cancer of the pancreas: 50 years of surgeryCancer, 1987
- Collective Review of Small Carcinomas of the PancreasAnnals of Surgery, 1986
- Effects of chronic administration of somatostatin on rat exocrine pancreasRegulatory Peptides, 1982
- Oestrogen receptor proteins in malignant and fetal pancreas.BMJ, 1981
- Steroid receptors in exocrine glands: The pancreas and prostateJournal of Steroid Biochemistry, 1979